sop fmd lpbe-sadc-final 8-11-10
TRANSCRIPT
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 1 of 16
SADC harmonized SOP for the detection of foot
and mouth disease virus (FMDV) antibodies using
liquid phase blocking ELISA
Version 1.0 Reviewed by G. Thobokwe1 and R. Dwarka2
Effective date: June 2010
Edited by:
E.M. Fana3 and S. Dibe4
This Standard Operating Procedure (SOP) is available at:
http://www.fao-ectad-gaborone.org
_______________ 1: C.VO- Botswana Vaccine Institute (BVI): 2: Head: ARC-OVI, South Africa: 3: Research Supervisor, BVI-SSRL Botswana; 4:
Scientist, BVI-SSRL, Botswana.
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 2 of 16
DISTRIBUTION LIST
This SOP has been prepared for use by National Veterinary Laboratories of the following SADC
member states:
o Botswana
o Lesotho
o Malawi
o Mozambique
o Namibia
o Swaziland
o Tanzania
o Zambia
o Zimbabwe
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 3 of 16
Contents:
1. Purpose
2. Principle
3. Materials and equipment
3.1 Chemicals
3.1.1 Coating buffer
3.1.2 Washing buffer (PBS)
3.1.3 Diluent
3.1.4 Blocking buffer
OPD OPTION
3.1.5 Phosphate citrate buffer
3.1.6 Chromogen
TMB OPTION
3.1.7 Blue substrate buffer
3.1.8 Chromogen solution
3.1.9 Substrate
3.1.10 Substrate/chromogen
3.1.11 Stopping solution
3.2 Reagents
3.2.1. Trapping antibody (Rabbit serum)
3.2.2 Detecting antibody (Guinea Pig serum)
3.2.3 Antigen stock
3.2.4 Anti-species conjugate
3.2.5 Positive and negative control sera
3.3 Consumables
3.3.1 Pipettes
3.3.2 Glassware/plastic ware
3.3.3 Reagent troughs
3.3.4 Micro plates
3.3.5 Tupperware containers
3.4 Apparatus
3.4.1 ELISA reader
3.4.2 Computer
3.4.3 Orbital Shaker
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 4 of 16
3.4.5 Refrigerator
3.4.6 Freezer
3.4.7 Incubator
3.4.8 pH meter
3.4.9 Balance
3.4.10 Timer
4. Method
4.1 Reagent and sample preparation
4.1.1 Trapping antibody stocks
4.1.2 Coating of micro titre plates
4.1.3 Detecting antibody stocks
4.1.4 Anti-species conjugate stocks
4.1.5 Antigen stocks
4.1.6 Dilution of test sera
4.2 Dilution of reagents
4.3 Blocking ELISA: Assay procedure
4.3.1 Plate layout + Addition of the control/test serum to a carrier plate
4.3.2 Mix antigen and sera
4.3.3 Addition of detecting antibodies
4.3.4 Addition of conjugate
4.3.5 Addition of substrate/chromogen and stopping solution
4.4 Recording of results
4.5 Calculation of results
4.6 Interpretation of results
Apendix
References
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 5 of 16
1. Purpose
The aim of the LPBE is to test sera of cloven-hoofed animal species for the presence of antibodies
against the structural proteins of FMDV. Antibodies directed against one or more type of FMDV can
either be identified (screening test) or quantified (titration test). The test has a very wide application.
Serum antibodies are induced against the outer capsid structural proteins following both vaccination
(domestic animals) against and infection (both domestic animals and game) with FMDV. Furthermore
it can be used to establish FMD free status in animals destined for import and export into the region
2. Principle
The test is a LPBE for the detection of FMDV antibodies in serum. The test is based upon specific
blocking of liquid phase FMD antigen by antibodies in the test serum sample. ELISA plates are coated
with anti-FMD antibody. Sera premixed with FMD antigen is then added to the coated plates. If
antibodies are present in the test sera, they will block the antigen and prevent it from binding to the
coating antibody. If there are no specific antibodies in the test sera then the antigen will be available
to be trapped on the plate, this will be detected by a positive colour indicating negative test results.
3. Materials and equipment
3.1 Chemicals
3.1.1 Coating buffer (Carbonate/bicarbonate buffer (0.05M))
To prepare 10x concentrated stocks
Sodium Hydrogen Carbonate (NaHCO3 0.5M; Merck,Sigma) ...................................................... 1.47g
Sodium Azide ............................................................................................................................. .1g
Sodium Carbonate anhydrous (Na2CO3 0.5M; Merck, Sigma) ...................................................... 0.79g
Distilled water ........................................................................................................................1 litre
Store at 4ºC+ 2ºC
pH9.6 + 0.05
3.1.2 Washing buffer (PBS)
To prepare concentrate:
Sodium chloride (NaCl; Merck, Sigma) ..................................................................................... 1600g
Potassium chloride (KCl; Merck, Sigma) ..................................................................................... 40g
Potassium dihydrogen orthophosphate (KH2PO4; Merck, Sigma) ........................................................... 40g
Disodium hydrogen phosphate dodecahydrate (Na2HPO4.12H2O; Merck, Sigma) ..................... 574,48g
Distilled water (up to) ..............................................................................................................6 litre
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 6 of 16
Dissolve completely
Set pH 7.2 – 7.4 (use HCl/NaOH)
Dispense in 175ml aliquots, store at +4ºC + 2ºC
To prepare washing buffer for use: dissolve 175ml in 5 litre distilled water
3.1.3 Diluent (PBST)
PBS ……………………………………………………………………………………………………………..…………………500ml
Tween-20 ………………………………………………………………………………………………………………..………250ul
Store at 4°C and use within 24hrs
3.1.4 Blocking buffer
Normal rabbit sera ……………………………………………………………………………………………………………...5ml
Normal Bovine sera ……………………………………………………………………………………………….…………...10ml
PBS ………………………………………………………………………………………………………..…………………………85ml
Store at -20°C
PBS-T milk
Skim milk (Merck,Unilab) .......................................................................................................... 100g
PBST ......................................................................................................................................2 litre
The pH must be constantly reset to neutral by adding drops of 0.5M NaOH.
Set pH 7.0-7.6
OPD OPTION
3.1.5 Phosphate citrate buffer
To Prepare 0.05M solution
Phosphate citrate buffer tablet (Sigma)………………………………..1
Distilled water……………………………………………………………………100ml
Set pH 5.0 (can be stored at room temperature for 1 month)
3.1.6 Chromogen
OPD tablet…………………………………………………………………………1
Phosphate citrate buffer----------------------------------------------55ml
Hydrogen Peroxide………………………………………………………………1/2000dilution i.e. 27.5µl
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 7 of 16
TMB OPTION
3.1.7 Blue substrate buffer
Solution A
Citric Acid Monohydrate (Merck, Sigma, Fluka) ............................................................................ 21g
Distilled water .........................................................................................................................1 litre
Solution B
Tri-Potassium Citrate (Merck, Sigma, Fluka) .............................................................................. 32,4g
Distilled water ........................................................................................................................1 litre
Mix solution A and solution B to obtain a pH 4
Store at 4ºC
3.1.8 Chromogen solution
N, N- Dimethylacetamide (DMA) (Merck, Sigma,Fluka) ............................................................. 100ml
Tetrabutylammonium borohydride (TBABH) (Merck, Sigma, Fluka) ............................................. 0,21g
3, 3’, 5, 5’-Tetramethylbenzidine (TMB) (Sigma, Merck, Fluka) ............................................... 0,9853g
Store in the dark at 2 - 8ºC
3.1.9 Substrate
H2O2 30% m/v (Merck analar)
Store at 4ºC
3.1.10 Substrate/Chromogen
The substrate/chromogen must be freshly prepared every time an ELISA is performed, just before use:
H2O2 ......................................................................................................................................... 30ul
Chromogen solution ................................................................................................................... 1ml
Blue substrate buffer ............................................................................................................. 100ml
Dissolve completely
3.1.11 Stopping solution
1.25M H2SO4 (Merck, Sigma, Fluka)
H2SO4 (98%) Merck, Sigma, Fluka) ............................................................................................ 67ml
Water with crushed ice ........................................................................................................... 933ml
To prepare stopping solution: add the concentrated acid very slowly to the water.
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 8 of 16
NOTE: Always add sulphuric acid to water - never add water to sulphuric acid
3.2 REAGENTS
3.2.1 Trapping antibody
The trapping antibody used is rabbit antiserum (whole serum) specific for the serotype of FMD.
3.2.2 Detecting antibody
The detecting antibody used is guinea-pig antiserum (whole serum) of the same specificity as the
trapping antibodies.
3.2.3 Control antigen stocks
FMD antigens used in the sandwich ELISA as positive control antigens are supernatant derived from
infected cell culture which has been inactivated with binary ethyleneimine (BEI). Negative control
antigens are prepared in a similar way as the positive antigens but from uninfected cell cultures.
3.2.4 Anti-species Conjugate
Rabbit anti guinea-pig IgG conjugated to horseradish peroxidase (Chemicon-Millipore- AQ108P).
3.2.5 Positive and negative control sera
3.3 Consumables
3.3.1 Pipettes
Single channel pipettes, variable ranges from 20-200 and 200-1000ul
Digital 12 Channel pipette, variable ranges from 50-300ul
combipette
Tips: blue and yellow tips
Combitips
3.3.2 Glassware/plasticware
A selection of beakers (25-1000ml), flasks (50-1000ml), graduated cylinders (50-1000ml), graduated
pipettes (1-10ml), bottles with screw caps 1-2000ml, dilution tubes (2-10ml) and suitable test tube
racks
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 9 of 16
3.3.3 Reagent Troughs
Reagent troughs suitable for simultaneous, multi-channel pipetting of a single reagent
3.3.4 Microplates
NUNC-Immuno Plate F96 Maxisorp (flat bottom)
NUNC-96 well Tissue culture plates (V/U shape) carrier plates
3.4 Apparatus
3.4.1 Photometer
Microplate reader (or similar) with an interference filter of 450/490nm. The photometer must be
interfaced with a PC
3.4.2 Computer (PC)
The appropriate software necessary for the calculation of ELISA results must be installed with Excel
3.4.3 Orbital Shaker
Orbital shaker (or similar) capable of rotating between 40 – 100rpm
3.4.4 Plate Washer optional (Hand wash)
Automated Microtitre plate washer. The inlet (of the plate washer) must be connected to two 20 litre
bottles containing washing buffer and distilled water respectively. The outlet of the plate washer must
be connected, via a waste collecting bottle, to a suitable vacuum source.
3.4.5 Refrigerator
Any type with a range between 2ºC - 6ºC
3.4.6 Freezer
-20ºC + 2ºC freezer
Ultrafreezer -70ºC + 5ºC
3.4.7 Incubator
Walk-in warm wall incubator with a range between 35ºC - 39ºC
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 10 of 16
3.4.8 pH meter
With an accuracy of 0.1 pH units
3.4.9 Balance
Analytical with sensitivity of 0,01g
3.4.10 Timer
An electronic timer with countdown capabilities and an audible alarm
4. Method
4.1 Plate layout + Addition of the control/test serum to a carrier plate
Prior to test, the type of test (screening/titration) and plate lay-out must be decided. Half titrations are
routinely used for screening to determine the immune status of the samples and full titrations are
done when the samples gives a reaction with the screening test.
Note: - The working concentrations of all produced reagents need to be optimized before a
new virus/antigen or trapping/detecting antibody or conjugate is introduced into the test.
When new control sera are introduced, they need to be tested several times until a good
range of titres is obtained. The running mean may then be accepted as early results may be
unrepresentative.
Pos
Ag
Tcc
Pos
Ag
Tcc
Pos
Ag
Tcc
Pos
Ag
Tcc
Pos
Ag
Tcc
Pos
Ag
Tcc
Serum Dil
1 2 3 4 5 6 7 8 9 10 Ca Ca
A S1 S1 S2 S2 S3 S3 S4 S4 S5 S5 Ca Ca 1/20
B S1 S1 S2 S2 S3 S3 S4 S4 S5 S5 Ca Ca 1/40
C S1 S1 S2 S2 S3 S3 S4 S4 S5 S5 Ca Ca 1/80
D S1 S1 S2 S2 S3 S3 S4 S4 S5 S5 Ca Ca 1/160
E S6 S6 S7 S7 S8 S8 S9 S9 S10 S10 C++ C++ 1/20
F S6 S6 S7 S7 S8 S8 S9 S9 S10 S10 C++ C++ 1/40
G S6 S6 S7 S7 S8 S8 S9 S9 S10 S10 neg neg 1/80
H S6 S6 S7 S7 S8 S8 S9 S9 S10 S10 neg neg 1/160
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 11 of 16
Plate layout for screening test
Pos Ag Positive antigen colum (50ul)
Tcc Negative antigen column (background - 50ul)
1 – 12 Column number
A – H Row number
C++ Strong control positive serum
Neg negative control
Ca Control antigen (Max OD – PBS/casein)
S1 – S10 Test serum
1/20 – 1/160 Serum dilution
Reference sera and test sera are titrated in duplicate wells against a reference antigen/virus in a
carrier plate starting with an initial dilution of 1/20. Add 50ul PBST to all wells then an extra 40ul PBST
to rows A 1-12, E1-12 and G11 & 12. Dilute by adding 10ul of the sample to 90ul of PBST. Referring
to the plate layout, make a twofold dilution series by transferring 50ul from row to row consecutively
discarding 50ul from the last dilution. Positive and negative sera are treated same way as samples and
diluted two fold.
4.1.1 Mix antigen and serum
Dilute pos antigen in PBST as per validated reagent dilution. Add 50ul of the diluted pos antigen to
columns 1, 3, 5, 7, 9, & 11 and Tcc (50ul PBST) to columns 2, 4, 6, 8, 10, & 12 of the carrier plate
with diluted serum. Incubate for 1h at 37oC + 2ºC on an orbital shaker or over night at 4oC + 2ºC.
4.1.2 Coating of microtitre plates
Microtitre plates are coated in bulk and then stored at -20ºC + 2ºC. Plates coated and stored in this
way can be used for both the sandwich and LPB ELISA for a period of one year.
Microtitre plates must be labeled according to date and the type of FMD virus with which they were
coated.
Trapping antibody stocks
For each strain of FMD virus used in the LPBE, prepare a coating serum stock dilution (rabbit
antiserum) of 1/100 to provide dilutions in carbonate buffer. This is aliquoted (5ml/ bottle) or less
depending on volume required per test. Store at -20ºC + 2ºC.
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 12 of 16
The stocks of the 1/100 diluted coating sera must be thawed and diluted just prior to use. Dilute
coating sera stocks in carbonate buffer pH 9.6 + 0.05. Thus, all coating sera are used at a
predetermined final dilution. The diluted coating serum is poured in a reagent trough and 100ul
dispensed to all the wells of a microtitre plate using a multi-channel pipette.
The plates are covered with plastic lids or plate sealers and incubated at 37oC+ 2ºC for 1h on a plate
shaker or overnight at 4oC+ 2ºC.
Plates are washed in the automate microplate washer with PBS (three cycles) then blot dried on tissue
paper or cloth.
The coated microtitre plates are now ready for use or it can be sealed in small plastic bags (two plates
per bag) and stored at -20oC+ 2ºC until needed.
Transfer 50ul of the antigen/serum mixture from the carrier plates to the corresponding wells of the
coated ELISA plates. For titrations, transfer row A first, followed by subsequent dilutions.
Incubate 1h/37oC + 2ºC on an orbital shaker. Wash the plate (3 times). Blot dry.
4.1.3 Detecting antibody stocks
The guinea-pig sera used as detecting antibody are pre-blocked with normal bovine serum (50% v/v).
This is done by mixing 10ml of guinea-pig sera and 10 ml of bovine sera. This is aliquoted in 10ml
volumes and stored at -20ºC + 2ºC. This is known as the ‘treated working stocks’ of the typing sera.
Addition of detecting antibody
The guinea-pig detecting (typing) serum for each type must be of the same specificity as the rabbit
coating sera for each microplate. Dilute the guinea-pig serum in PBST-milk as per validation report
and add 50ul to all wells of all plates. Plates are sealed and incubated for 1h at 37oC + 2ºC on an
orbital shaker. Wash plates three times with a plate washer and blot dry.
4.1.4 Anti-species conjugate stocks
Reconstitute according to supplier’s instructions then dilute it with PBS to 1/100. Before using the
conjugate it is blocked at 1:1 with blocking buffer making final concentration of 1/200. Store in
aliquots of 1.0 ml in -70ºC + 2ºC. Just before use an ampoule is thawed and diluted as per validation
report.
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 13 of 16
Addition of conjugate
Prepare a working dilution as described above of the conjugate in PBST-milk in a volume sufficient for
all microplates (5ml/plate) just before use. Pour conjugate in a reagent trough and distribute 50ul to
the wells of all the plates with a multi channel pipette. Plates are incubated for 1h at 37oC + 2ºC on an
orbital shaker as before. Plates are washed three times with plate washer and blot dried.
4.2.5 Substrate/chromogen and stopping solution stocks
Prepare chromogen solution as described in 3.1.10 in a volume sufficient for the number of plates
being used (10ml/plate) just before use. Prepare stopping solution as described in 3.1.11.
Addition of substrate/chromogen and stopping solution
A clean microtitreplate will be used for blanking the photometer. After washing the plates, pour
substrate/chromogen into a reagent trough. Start electronic timer. Distribute 100ul to all the wells of
the microtitre plates, including the blanking plate, with a multi-channel pipette. After incubation at
room temperature for 15 + 5 minutes, the reaction (colour development) is stopped by the addition of
50ul of stopping solution to all the wells of the plates.
4.3 Recording of results
Plates are read with the Thermo Multiskan EX at 450nm if using blue substrate buffer chromogen
(TMB option) or 492nm if using phosphate citrate buffer chromogen (OPD option). Blank the plate
reader as appropriate. Place an ELISA plate in the reader and initiate the reading sequence.
The Multiskan interfaces with a PC which receives readings from the Multiskan. The readings are
transferred to a spreadsheet which contains statistical formulae which perform calculations according
to specifications, presenting results in an acceptable format. The formulae are described in 4.4.
4.4 Calculation of test sera percentage inhibition for LPBE
The serum titre is calculated as that dilution where a 50% reduction of the colour reaction is recorded.
Antibody titres are expressed as the 50% end-point titre, i.e. the dilution at which the reaction of the
test sera results in an optical density of the reaction (antigen) control wells (Kärber method).
Titres > 1/40 should be retested using the VN test.
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 14 of 16
Calculation of ODCa / Max OD
ODCa = [Average (A11, B11, C11, D11)] – [Average (A12, B12, C12, D12)]
(Note: A11 to D11 is applicable for screening tests, full titrations will go down to H11)
Calculation of OD’s for each sample dilution
Corrected OD = OD Pos Ag – OD Tcc
e.g. Corrected OD’s for sample 1:
corrected OD s1 1st dilution = A1 – A2
corrected OD s2 1st dilution = B1 – B2
corrected OD s3 1st dilution = C1 – C2
corrected OD s4 1st dilution = D1 – D2
Calculation of percentage inhibition for each sample dilution
Percentage inhibition = 100-[(Corrected OD sample / Corrected OD Ca ) x 100]
Average of Median OD of antigen control (Max OD)
The Percentage Inhibitions for the four dilutions of each sera (PI 1, PI2, PI3, PI4) are used to
calculate the serum titre.
NOTE
If % Inhibition < 50 Then = Negative
If % Inhibition ≥ 50 Then = Positive
Calculation of serum titres
Log titre = [((ΣPI 1+ PI 2 + PI 3 + PI 4)/100) – 05]*Log serial dilution (2) + Log starting
dilution (1)
Serum titre = Antilog of TCID 50
Acceptance of assay
The assay is accepted if the results meet the following criteria:
a. The titer of the reference sera should not be more than 2 fold of the running mean.
b. The negative control should be <50% inhibition
c. The titer of the strong positive sera should be >128.
d. The titer of the weak positive should be in the range of 45-128.
Note: Test results may still be acceptable when the positive control falls out of the range of criteria,
on the condition that all other controls pass and at the discretion of the line manager or an
experienced, competent operator.
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 15 of 16
4.5 Interpretation of results
a. Imported/exported/post vaccination samples
Titre of a sample ≥45 Positive
Titre of a sample <45 Negative
b. suspected FMD cases
Titre of a sample ≥90 Positive
Titre of a sample <64 Negative
The titre of a sample in the range of 64-90 is inconclusive
Note: Positive samples or inconclusive results are confirmed by VNT.
Appendix 1
LAF-cab laminar air flow cabinet
FMDV foot-and-mouth disease virus
FMD antigen inactivated FMD virus used in ELISA
ELISA Enzyme linked immuno sorbent assay
SAT Southern Africa type
PBS Phosphate Buffered Saline
H2O2 Hydrogen peroxide
H2SO4 Sulphuric acid
BEI Binary ethyleneimmine
LPBE Liquid Phase Blocking ELISA
Appendix 2 diagrammatic representation of Liquid Phase Blocking Elisa (LPBE)
SOP FMD 5: Detection of Antibodies against Foot-and-Mouth Disease Virus (FMDV) in a Liquid Phase Blocking ELISA (LPBE)
SOP FMD Compiled by: G.Thobokwe and R. Dwarka Issued by:
Revision Authorised by: Issue date: June 2010
Page 16 of 16
IRS = immune rabbit serum IGPS = immune guinea pig serum (antibody) HRPO = horseradish peroxidase (enzyme conjugated antibody) OPD = substrate
References
Hamblin, C., Barnett, I.T.R. and Hedger, R.S. (1986) A new enzyme-linked immunosorbent assay
(ELISA) for the detection of antibodies against foot-and-mouth disease virus. I Development. J.
Immun. Meth. 93, 115-121
Hamblin, C., Barnett, I.T.R. and Hedger, R.S. (1986) A new enzyme-linked immunosorbent assay
(ELISA) for the detection of antibodies against foot-and-mouth disease virus. II Application. J. Immun.
Meth. 93, 123-129
Karber, G (1931) 50% end-point calculation. Arch. Exp. Pathol. Pharmak., 162, 480-48.
Manual of standards for diagnostic tests and vaccine. Office International des Epizooties.
http://www.oie.int/eng/normes/mmanual/2008/pdf/2.01.05_fmd.pdf
IRS
FMD Antigen
IGPS
HRP Substrate
Coloured Product